Real-World Impact
CEO Insight featured Dr. Michael Wilkinson on its cover, recognizing his
leadership in pioneering synthetic healthcare experts through Inavya. Forbes also
spotlighted the company’s innovative AI solutions, transforming access to care. A
powerful example of AVATR AI’s real-world impact comes from Peru, where it
supported health workers and patients in remote regions with limited internet
access.
Using WhatsApp and a secure micro-cloud system developed with HealthSum
AS—based in Norway and Switzerland—AVATR AI created personalized digital
identities that captured each patient’s language, behaviors, and local context.
This enabled early clinical trial enrollment, personalized care, and improved
continuity—all directly through mobile devices. The result was increased patient
engagement, digital access, and participation in health research.
This success has been shared with UN health teams and NGOs as a model for
responsible AI deployment in underserved communities. Building on this
momentum, Inavya is now expanding into regions across Africa, Asia, and Latin
America, ensuring AVATR AI’s culturally sensitive and accessible healthcare
support reaches those who need it most.
Implementation in Eight Countries
AVATR AI plans to soon launch TRL-8 validation program across eight countries:
Norway, Switzerland, Brazil, Peru, USA, India, Ghana, and Singapore. This
18-month program aims to test the platform’s real-world use, clinical impact, and
readiness for wider adoption. So far, AVATR AI has shown faster onboarding,
better patient engagement, and strong adaptability in multilingual and
low-resource settings. It is expected to reach TRL-9 by the third quarter of 2027,
providing a clear route-map as a scalable and essential solution for the future of
inclusive, patient-centered healthcare.